Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company dedicated to developing neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. The Company has developed its FDA-510(k) cleared Brain Network Analytics (BNA) software platform (the BNA Platform) and is focused on advancing diagnostic and treatment approaches for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder (ADHD). BNA, utilizing AI and an extensive proprietary electroencephalogram (EEG) database, combines the automatic analysis of Event Related Potentials (ERPs), spectral EEG and behavioral performance data for a comprehensive, and objective data-driven brain health evaluation. The BNA Platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition).
Símbolo de cotizaciónAIFF
Nombre de la empresaFirefly Neuroscience Inc
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoMr. Greg Lipschitz
Número de empleados13
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 27
Dirección1100 Military Road
CiudadKENMORE
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal14217
Teléfono18882376412
Sitio Webhttps://fireflyneuro.com/
Símbolo de cotizaciónAIFF
Fecha de salida a bolsaOct 27, 1993
Director ejecutivoMr. Greg Lipschitz
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos